2011
DOI: 10.1016/j.neubiorev.2010.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
162
0
4

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 238 publications
(172 citation statements)
references
References 145 publications
6
162
0
4
Order By: Relevance
“…Dyreforsøk tyder ikke på at noen cytostatikatyper gir mer kognitive problemer enn andre (11). Det er heller ikke påvist sammenheng mellom hvilke ledningsbaner som skades og type cellegift.…”
Section: Andre Forhold Av Betydningunclassified
“…Dyreforsøk tyder ikke på at noen cytostatikatyper gir mer kognitive problemer enn andre (11). Det er heller ikke påvist sammenheng mellom hvilke ledningsbaner som skades og type cellegift.…”
Section: Andre Forhold Av Betydningunclassified
“…En diversos modelos animales se ha detectado una relación consistente entre la administración de quimioterapia y la alteración de algunos dominios cognitivos (9) . Así por ejemplo, El 5FU y el MTX causan en ratones déficits agudos en ciertas funciones cognitivas que requieren la integridad del hipocampo y del lóbulo frontal (3) .…”
Section: Toxicidad Neurológica Inducida Por Los Quimioterápicosunclassified
“…Radiation is well-known to affect different brain structures, including the neural stem cells as well as the glial and vascular (Sundgren andCao, 2009), (Acharya et al, 2010). In addition, majority of the chemotherapeutics used for ALL treatments have numerous effects on the brain, increasing the oxidative stress, reducing neurogenesis, affecting the blood flow and generating white matter damage (Seigers and Fardell, 2011). Previous research has shown that some chemotherapy drugs including cytosine arabinoside as well as radiation (Monje et al, 2002) are toxic at therapeutic doses for the neural stem/progenitor cells (Seigers et al, 2008).…”
Section: Further Directions: Neuroprotective and Restorative Treatmentsmentioning
confidence: 99%